The agenda for the 2017 Personalized and Precision Medicine Conference has not yet been announced. The following is a draft agenda:
R & D: Trends & Challenges in Diagnostics and Therapeutics
Not too long ago the central focus of basic biomedical research was to translate findings into patient and consumer –end products and solutions. However, rapidly advancing scientific, technological and societal developments enable us to now combine the best science with applications in real time, including data collection. The ability to quantify physiologies and genetic make-ups as well as patients using omics based and imaging technologies is increasing.
Omics analysis permits a comprehensive analysis of molecules (genes/transcripts/proteins/lipids/metabolites). The increasing self-quantification movement and citizen science research projects are disrupting the population average database model- as individuals are now sharing n-of-1- data. System thinking and computational methods are now used to analyze and visualize biological systems. Increasingly, environmental exposure and life style factors are collected and informing network based methods describing health, subsystems of physiological processes and pathological states.
Ultimately, these strategies are enabling us to provide better solutions that can be applied in real time to assess, mitigate, improve or delay disease symptoms and maintain health. The cost of point of care tests is decreasing. More drug applications now having biomarker labels. Clinical research data management is changing resulting in greater efficiencies. The increasing number of million person cohorts and large-scale databases is global. This section will discuss how these disruptions are improving R & D.
Technologies Revolutionizing Precision Medicine
Technological innovations including but not limited to new computational platforms and methods, machine learning, digital imaging, medical decision support tools and their impact on improving our understanding of disease processes, detection, treatment and prevention will be discussed by experts and innovators. New technologies will help integrate combinations of genomic, clinical and life style data, which in turn will greatly increase in the next 3-5 years, filling a previously important gap in translational genomic knowledge This panel will present exciting new innovations and how they are advancing PM.
Beyond Oncology: Infectious Disease, CNS Disease and Cardiovascular Disease
Genomics, and the related omics, are improving our understanding of the biological complexities and physiological processes involved in infectious, CNS and cardiovascular disease and therefore the ability of Precision Medicine to impact detection, treatment, prevention, and chronic care. Talks will discuss key advances in these respective fields, and the success and challenges in implementing precision into clinical management.
A. Infectious Disease: The ability to detect and tract the spread infectious pathogens, has vastly improved in recent years thanks to genomic and technological applications. This has led to a significant ability to better contain the spread of such pathogens.
B. Central Nervous System: Important advances are being made in Neurogenomics and Psychiatry, including the use of Pharmacogenomics to improve care and patient outcomes.
C. Cardiovascular Disease: Greater opportunities to use genomics to improve detect, treatment, management and prevention now exist and are growing rapidly. For example, biomarkers are increasingly used to detect and treat heart failure, advances are being applied in pediatric cardiology and advances in cardiac pharmacotherapy have been made.
Harnessing Big Data For Research & Clinical Application
Large-scale data analysis is transforming the way we diagnose, treat and prevent disease. This section addresses a range of challenges in improving the access, portability, sharing and storage of personal genomic data. Accessing ‘locked’ databases whose data is available only for a cost versus publically available data, is but one such challenge.
Patient Engagement, Empowerment & Ethical Issues
The blurring of research and clinical practice, as well as increased patient/citizen engagement has led to a range of ethical issues, including but not limited to if/when a duty to warn exists, whether patients ought to be in control of their own data, how to handle privacy and confidentiality given that evidence shows that personal identification is feasible from analyzing anonymized data bases and how to eradicate health disparities among African American and Latinos. This section will address the primary issues in the context of a changing health care environment that gives and expects greater patient accountability for one’s health. Speakers will discuss the powerful impact of patient engagement and the various ethical issues in ensuring that patients have access to their data, if they so choose, as well as to the diagnostics, treatments and management strategies they have helped to develop by sharing their personal data.
Panel: From Research to Clinical Adoption: Drivers, Barriers, and Designing Success Strategies
Implementing innovation in clinical medicine increasingly requires adoption by health care institutions. The adoption process has always been, and remains, a formidable challenge due to various factors including; institutional barriers, cost, lack of knowledge, skill or motivation. This panel of discusses a range of drivers, barriers and possible solution strategies to expedite efficient and effective implementation of evidence based solutions.
Global Experiences in Integrating Genomics (omics) and Related Technological Advances into Practice
Although personalized medicine has improved health care and will continue to grow, implementing innovation into health care systems is not without significant challenges. This panel will discuss approaches to integrating PM in clinical care in various institutions outside the US. Lessons learned and best practices will be shared.
Our events give attendees a conference experience that encompasses learning, networking and professional growth. We strive to facilitate connections. At our events, attendees, speakers, sponsors and exhibitors have opportunities to network and then to utilize those connections to further their professional goals. At Arrowhead Publishers, our focus is on bringing life sciences industry professionals together to help move research forward. Learn more about us at www.arrowheadpublishers.com.
For general information about the conference, please contact us at:
5780 Lincoln Drive, Suite 205, Edina, Minnesota 55436 USA